DK521585A - Fysisk stabilt anthelmintisk pastapraeparat - Google Patents

Fysisk stabilt anthelmintisk pastapraeparat Download PDF

Info

Publication number
DK521585A
DK521585A DK521585A DK521585A DK521585A DK 521585 A DK521585 A DK 521585A DK 521585 A DK521585 A DK 521585A DK 521585 A DK521585 A DK 521585A DK 521585 A DK521585 A DK 521585A
Authority
DK
Denmark
Prior art keywords
anthelmintic
physical stable
past preparation
stable anthelmintic
past
Prior art date
Application number
DK521585A
Other languages
English (en)
Other versions
DK521585D0 (da
DK170484B1 (da
Inventor
James Michael Quinlan
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK521585D0 publication Critical patent/DK521585D0/da
Publication of DK521585A publication Critical patent/DK521585A/da
Application granted granted Critical
Publication of DK170484B1 publication Critical patent/DK170484B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Lift-Guide Devices, And Elevator Ropes And Cables (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Noodles (AREA)
DK521585A 1984-11-13 1985-11-12 Fysisk stabilt, anthemintisk kombinationspræparat i form af en pasta indeholdende resineret tetramisol DK170484B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67083984A 1984-11-13 1984-11-13
US67083984 1984-11-13

Publications (3)

Publication Number Publication Date
DK521585D0 DK521585D0 (da) 1985-11-12
DK521585A true DK521585A (da) 1986-05-14
DK170484B1 DK170484B1 (da) 1995-09-18

Family

ID=24692106

Family Applications (1)

Application Number Title Priority Date Filing Date
DK521585A DK170484B1 (da) 1984-11-13 1985-11-12 Fysisk stabilt, anthemintisk kombinationspræparat i form af en pasta indeholdende resineret tetramisol

Country Status (10)

Country Link
US (1) US4781920A (da)
EP (1) EP0181525B1 (da)
JP (1) JPH0647538B2 (da)
AT (1) ATE80299T1 (da)
AU (1) AU586202B2 (da)
CA (1) CA1256376A (da)
DE (1) DE3586620T2 (da)
DK (1) DK170484B1 (da)
ES (1) ES8605154A1 (da)
ZA (1) ZA858673B (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206621B (en) * 1989-08-10 1992-12-28 Chinoin Gyogyszer Es Vegyeszet Process for producing veterinary compositions containing lyotrope liquide christalline benzimidazol derivative
EP0505389B1 (en) * 1989-12-19 1997-05-14 Smithkline Beecham Corporation Antiparasitic composition for animal use
DE69412940T2 (de) * 1993-02-17 1999-05-12 Dade Behring, Inc., Deerfield, Ill. Verfahren und zusammensetzung zur verminderung der effekte von endogener alkalischer phosphatase
CA2259469A1 (en) 1996-06-05 1997-12-11 Ashmont Holdings Limited Injectable compositions
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040180034A1 (en) * 2003-03-10 2004-09-16 Lyn Hughes Anthelmintic resinates and a method for their preparation
US20070036843A1 (en) * 2005-01-28 2007-02-15 Collegium Pharmaceutical, Inc. Non-ionic non-aqueous vehicles for topical and oral administration of carrier-complexed active agents
CN102181021B (zh) * 2011-02-18 2012-12-05 中北大学 用于手性四咪唑分离提纯的新材料的制备方法
CN104215767B (zh) * 2014-09-25 2016-09-07 句容市农业技术推广中心 一种氨磺磷胶体金快速检测试纸条及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053733A (en) * 1959-07-27 1962-09-11 Pfizer & Co C Anthelmintic composition and method of using same
US3166472A (en) * 1962-01-12 1965-01-19 Shell Oil Co Anthelmintic compositions and method of employing same
US3535419A (en) * 1965-12-15 1970-10-20 Syntex Corp Veterinary compositions and methods
US3632692A (en) * 1967-07-21 1972-01-04 Shell Oil Co Organophosphorus anhydrides
US3862312A (en) * 1968-01-08 1975-01-21 Ici Ltd Compositions comprising a resinate of dl- or l-tetramisole, and treatment therewith
GB1174221A (en) * 1968-01-08 1969-12-17 Ici Ltd Acid-addition Salts of Tetramisole
CA946742A (en) * 1969-06-27 1974-05-07 James M. Quinlan 1 and d1 tetramisole resinates and method for preparation thereof
US4336262A (en) * 1973-02-23 1982-06-22 Fisons Ltd. Pour-on veterinary anthelmintic
US3937825A (en) * 1973-09-21 1976-02-10 American Cyanamid Company Anthelmintic composition and method of use
US4197307A (en) * 1977-04-12 1980-04-08 Ciba-Geigy Corporation 2-Alkylthio-, 2-alkylsulphinyl- and 2-alkylsulfonyl-6-phenylbenzimidazoles as anthelmintic agents
NZ191413A (en) * 1978-09-11 1981-10-19 Ici Australia Ltd Anthelmintic and anticlostridial composition containing a tetramisole salt
DE2841882A1 (de) * 1978-09-26 1980-04-03 Bayer Ag Endoparasitizide pasten fuer pferde
FR2475396A1 (fr) * 1981-01-02 1981-08-14 Noe Elevage Service Sica Procede pour augmenter l'efficacite des vaccins, compositions de vaccins contenant un immunostimulant en particulier de la famille des benzimidazoles et de la famille des imidazothiazoles, et applications dans le domaine veterinaire
GB2124904B (en) * 1982-08-13 1986-01-15 Ciba Geigy Ag Synergistic anthelmintic compositions
AU563170B2 (en) * 1983-05-27 1987-07-02 Australian National University, The Anthelmintic composition containing levamisole and benzimidazoles

Also Published As

Publication number Publication date
DE3586620D1 (de) 1992-10-15
ZA858673B (en) 1986-07-30
JPH0647538B2 (ja) 1994-06-22
AU4978785A (en) 1986-05-22
EP0181525A3 (en) 1987-06-03
ATE80299T1 (de) 1992-09-15
US4781920A (en) 1988-11-01
ES8605154A1 (es) 1986-04-01
ES548746A0 (es) 1986-04-01
CA1256376A (en) 1989-06-27
EP0181525A2 (en) 1986-05-21
EP0181525B1 (en) 1992-09-09
DK521585D0 (da) 1985-11-12
AU586202B2 (en) 1989-07-06
JPS61122213A (ja) 1986-06-10
DE3586620T2 (de) 1993-04-08
DK170484B1 (da) 1995-09-18

Similar Documents

Publication Publication Date Title
IL85704A0 (en) Thiazole derivatives,their preparation and pharmaceutical compositions containing them
PH23505A (en) Pharmaceutical suspension formulations containing cimetidine
BR8801905A (pt) Composicoes elastomericas de halobutila
SE8404065D0 (sv) Novel biologically active compounds
DK521585A (da) Fysisk stabilt anthelmintisk pastapraeparat
GB2198352B (en) Pharmaceutical compositions containing ranitidine
IL86890A0 (en) Thiourea derivatives,their preparation and pharmaceutical compositions containing them
IL78090A (en) Substituted 1,3-thiazole sulfides,process for their preparation and pharmaceutical compositions containing them
NZ211960A (en) Benz(5,6)isoindolo(2,1-b)isoquinoline-8,13-dione derivatives and pharmaceutical compositions
DE3061614D1 (en) 2,3-dihydro-imidazo (2,1-b) benzothiazole derivatives and pharmaceutical compositions containing them
NZ216876A (en) Fungicidal and anthelmintic compositions containing bithionol sulphoxide
IL65443A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
EP0226842A3 (en) Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them
IL67720A (en) Substituted 1,3,4-thiadiazolo(3,2-a)-pyrimidines,their preparation and pharmaceutical compositions containing them
IL66146A (en) Substituted benzylidenepyrrolo-(2,1-b)quinazolinones and pyrido-(2,1-b)quinazolinones,their preparation and pharmaceutical compositions containing them
SE8503447D0 (sv) Farmaceutiska och kosmetiska kompositioner, innehallande dihydroxi-1,8-fenyl-10-antron-9 som verksam bestandsdel, samt sett att framstella den verksamma foreningen
ZA852340B (en) Stabilised anthelmintic formulations
HK81789A (en) Anthelmintic imidazo(2,1-b)thiazole gel compositions
IL85924A0 (en) Thienoimidazo(2,1-b)-thiazole derivatives,their preparation and pharmaceutical compositions containing them
IL69274A (en) (substituted amino)derivatives of 3-benzylidene-pyrrolo(2,1-b)quinazolin-9-ones and 6-benzylidene-pyrido(2,1-b)quinazolin-11-ones,their preparation and pharmaceutical compositions containing them
IL84857A0 (en) Pharmaceutical compositions containing certain pyranoquinoline derivatives
IL82738A0 (en) Cephalosporin compounds,their preparation and pharmaceutical compositions containing them
ZA863500B (en) Novel anthelmintic compositions
ZA89130B (en) Preparation of 5,8,13,14-tetrahydrobenz(5,6)isoindolo(2,1-b)isoquinolin-8,13-dione derivatives
GB2195081B (en) Anthelmintic composition

Legal Events

Date Code Title Description
PBP Patent lapsed

Country of ref document: DK